ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
Generic: ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
Dr. Reddy's Laboratories LimitedManufacturer
ORALRoute
ENALAPRIL MALEATEActive Substance
2001-10-15Original Approval
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE is FDA application ANDA075909, sponsored by PHARMAZONE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-03-16
Enalapril Maleate Tablets, USP; 2.5 mg; 90 tablets, NDC 60429-183-90; manufactured by Taro Pharmaceutical Industries, LtCGMP Deviations
Class II2022-03-16
Enalapril Maleate Tablets, USP; 10 mg; 90 tablets, NDC 60429-185-90; manufactured by Taro Pharmaceutical Industries, LtdCGMP Deviations
Class II2022-03-16
Enalapril Maleate Tablets, USP; 5 mg; 90 tablets, NDC 60429-184-90; manufactured by Taro Pharmaceutical Industries, Ltd.CGMP Deviations
Class II2026-04-23
Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurit
Class II2022-03-16
Enalapril Maleate Tablets, USP; 20 mg; 90 tablets, NDC 60429-186-90; manufactured by Taro Pharmaceutical Industries, LtdCGMP Deviations
Top Reported Reactions
1
DIARRHOEA
2,926 reports
2
DYSPNOEA
2,732 reports
3
NAUSEA
2,658 reports
4
DRUG INEFFECTIVE
2,627 reports
5
FATIGUE
2,458 reports
6
DRUG INTERACTION
2,451 reports
7
DIZZINESS
2,306 reports
8
ACUTE KIDNEY INJURY
2,133 reports
9
VOMITING
2,051 reports
10
HEADACHE
1,875 reports